Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Apr 09 2026

Apr 9, 2026 at 8:50 AM EDT · Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · Apr 9, 2026 at 8:50 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/press-release-apr-09-2026-15

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled "Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Press Release Apr 01 2026Apr 1
Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S., Significantly Expanding Its Innovative PortfolioApr 1
Press Release Mar 21 2026Mar 21
Press Release Mar 19 2026Mar 19
Press Release Mar 16 2026Mar 16

Later from Glenmark Pharmaceuticals

Press Release May 18 2026May 17
Press Release May 20 2026May 20
Press Release May 29 2026May 29
Press Release Jun 05 2026Jun 4
Glenmark Pharmaceuticals Limited Press Release Jun 11 2026Jun 11

All Glenmark Pharmaceuticals news releases

Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.

Follow Glenmark Pharmaceuticals